EmergoPharm Overview

  • Year Founded
  • 2009

Year Founded

  • Status
  • Acquired/​Merged

  • Employees
  • 7

Employees

  • Latest Deal Type
  • Buyout/​LBO

  • Financing Rounds
  • 1

EmergoPharm General Information

Description

Provider of research, development, and supply services intended for the pharmaceutical and healthcare sectors. The company offers medical devices, dietary supplements, cosmetics, medicinal products, contract manufacturing services, registration and manufacturing documentation, pharmaceutical consultancy, product design support, and specialty services to help clients develop products.

Contact Information

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Private Equity-Backed
Corporate Office
  • Ulega Jana Ciszewskiego 15
  • Warsaw, 02-777
  • Poland
+48 690
Primary Industry
Other Healthcare Services
Other Industries
Pharmaceuticals
Parent Company
Vertical(s)
Corporate Office
  • Ulega Jana Ciszewskiego 15
  • Warsaw, 02-777
  • Poland
+48 690

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

EmergoPharm Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore EmergoPharm‘s full profile, request access.

Request a free trial

EmergoPharm Patents

EmergoPharm Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4635522-A1 Pharmaceutical composition for preventing of abnormal scars growth and treatment of scars Pending 15-Apr-2024
CA-3066602-A1 Application of totarol and pharmaceutical composition containing totarol Active 06-Jul-2017
CA-3066602-C Application of totarol and pharmaceutical composition containing totarol Active 06-Jul-2017
EP-3648751-A1 Application of totarol and pharmaceutical composition containing totarol Active 06-Jul-2017
EP-3648751-B1 Application of totarol and pharmaceutical composition containing totarol Active 06-Jul-2017 A61K31/05
To view EmergoPharm’s complete patent history, request access »

EmergoPharm Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

EmergoPharm FAQs

  • When was EmergoPharm founded?

    EmergoPharm was founded in 2009.

  • Where is EmergoPharm headquartered?

    EmergoPharm is headquartered in Warsaw, Poland.

  • What is the size of EmergoPharm?

    EmergoPharm has 7 total employees.

  • What industry is EmergoPharm in?

    EmergoPharm’s primary industry is Other Healthcare Services.

  • Is EmergoPharm a private or public company?

    EmergoPharm is a Private company.

  • What is EmergoPharm’s current revenue?

    The current revenue for EmergoPharm is .

  • When was EmergoPharm acquired?

    EmergoPharm was acquired on 28-Sep-2026.

  • Who acquired EmergoPharm?

    EmergoPharm was acquired by Biofarma (Italy).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process